Case report: Misdiagnosis of primary mucinous cystadenoma of the testicle by ultrasound.
cystadenoma
diagnostic errors
mucinous
testicle
ultrasound
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2023
2023
Historique:
received:
16
04
2023
accepted:
21
08
2023
medline:
21
9
2023
pubmed:
21
9
2023
entrez:
21
9
2023
Statut:
epublish
Résumé
Testicular mucinous cystadenoma is a rare benign testicular tumor with the characteristics of being potentially malignant and showing atypical clinical symptoms; this article reports a case of a primary testicular mucinous cystadenoma misdiagnosed as testicular teratoma by ultrasound. A 69-year-old man was admitted to the hospital because of a 1-year history of left-sided testicular enlargement with scrotal swelling and no obvious abnormalities on laboratory tests. Ultrasound examination revealed solid-mass lesions in the left testicle, suggesting a high probability of teratoma, and contrast-enhanced magnetic resonance imaging (MRI) examination suggested an increased possibility of epidermoid cysts. Contrast-enhanced computed tomography (CT) and contrast-enhanced MRI of the preoperative abdomen and pelvis showed no other primary adenocarcinoma. Doctors performed radical resection of the left testicle. The postoperative pathological diagnosis was mucinous cystadenoma, and calcification as well as partially mildly atypical epithelial cells were discovered. Furthermore, there were no neoplastic lesions in the epididymis or spermatic cord. No metastatic lesions were found after 6 months postoperative follow-up, and the patient's prognosis remains good.
Identifiants
pubmed: 37731639
doi: 10.3389/fonc.2023.1206697
pmc: PMC10508290
doi:
Types de publication
Case Reports
Langues
eng
Pagination
1206697Informations de copyright
Copyright © 2023 Zhang, Xuan, Li, Zhang, Song, Pan, Fan, Lu, Zhou and Li.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Radiol Case Rep. 2023 Jun 30;18(9):3203-3205
pubmed: 37448604
Case Rep Oncol Med. 2015;2015:863745
pubmed: 25821618
BMJ Case Rep. 2018 Oct 3;2018:
pubmed: 30287624
Arch Pathol Lab Med. 2006 Nov;130(11):1715-7
pubmed: 17076537
Insights Imaging. 2020 May 27;11(1):74
pubmed: 32462465
Arch Pathol Lab Med. 1999 Mar;123(3):244-6
pubmed: 10086514
J Pathol Transl Med. 2017 Mar;51(2):180-184
pubmed: 28189139
Cancer. 1968 May;21(5):852-70
pubmed: 4870093
Pathol Int. 2002 Oct;52(10):648-52
pubmed: 12445137
Front Oncol. 2021 Mar 09;10:619774
pubmed: 33767975
Arch Pathol Lab Med. 2005 Mar;129(3):399-402
pubmed: 15737039
Am J Surg Pathol. 2003 Sep;27(9):1221-8
pubmed: 12960806
J Urol. 2004 Jul;172(1):146-7
pubmed: 15201756
Cancers (Basel). 2022 Jun 29;14(13):
pubmed: 35804952
Urol Int. 2008;81(1):119-21
pubmed: 18645284
Histopathology. 1998 Aug;33(2):193-4
pubmed: 9762558
Cancers (Basel). 2022 Aug 11;14(16):
pubmed: 36010875
Hum Pathol. 2011 Sep;42(9):1343-7
pubmed: 21396680
J Urol. 1976 Apr;115(4):472-3
pubmed: 944277
Cancer. 1959 Jan-Feb;12(1):187-90
pubmed: 13618869
Arch Pathol Lab Med. 1992 Dec;116(12):1360-3
pubmed: 1456884
Pathol Int. 2004 May;54(5):355-9
pubmed: 15086841
Eur Urol. 2022 Nov;82(5):458-468
pubmed: 35853783
J Urol. 1988 Sep;140(3):621-2
pubmed: 3411689
Cancer. 1984 Aug 15;54(4):709-14
pubmed: 6204734
Urology. 1979 Sep;14(3):280-4
pubmed: 483506
Can Urol Assoc J. 2015 Nov-Dec;9(11-12):E814-6
pubmed: 26600891
Can Urol Assoc J. 2010 Aug;4(4):E112-5
pubmed: 20694089
Pathology. 2005 Feb;37(1):92-4
pubmed: 15875745
J Cancer Res Ther. 2015 Jul-Sep;11(3):647
pubmed: 26458610